共 14 条
- [1] Pacini F., Schlumberger M., Harmer C., Berg G.G., Cohen O., Duntas L., Jamar F., Jarzab B., Limbert E., Lind P., Reiners C., Franco F.S., Smit J., Wiersinga W., Post-surgical use of radioiodine (<sup>131</sup>I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: A consensus report, European Journal of Endocrinology, 153, 5, pp. 651-659, (2005)
- [2] Mazzaferri E.L., Thyroid remnant <sup>131</sup>I ablation for papillary and follicular thyroid carcinoma, Thyroid, 7, 2, pp. 265-271, (1997)
- [3] McCowen K.D., Adler R.A., Ghaed N., Verdon T., Hofeldt F.D., Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer, Am J Med, 61, pp. 52-8, (1976)
- [4] Bal C., Padhy A.K., Jana S., Pant G.S., Basu A.K., Prospective randomized clinical trial to evaluate the optimal dose of 131 i for remnant ablation in patients with differentiated thyroid carcinoma, Cancer, 77, pp. 2574-80, (1996)
- [5] Johansen K., Woodhouse N.J., Odugbesan O., Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer, J Nucl Med, 32, pp. 252-4, (1991)
- [6] Maenpaa H.O., Heikkonen J., Vaalavirta L., Tenhunen M., Joensuu H., Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: A randomized study, PLoS ONE, 3, 4, (2008)
- [7] Pacini F., Ladenson P.W., Schlumberger M., Driedger A., Luster M., Kloos R.T., Sherman S., Haugen B., Corone C., Molinaro E., Elisei R., Ceccarelli C., Pinchera A., Wahl R.L., Leboulleux S., Ricard M., Yoo J., Busaidy N.L., Delpassand E., Hanscheid H., Felbinger R., Lassmann M., Reiners C., Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study, Journal of Clinic
- [8] Gawkowska-Suwiska M., Ocena Wczesnej Skutecznoci Leczenia Uzupeniajcego Izotopem Jodu 131 i Chorych Na Zránicowanego Raka Tarczycy, (2003)
- [9] Gawkowska-Suwiska M., Turska M., Roskosz J., Puch Z., Jurecka-Tuleja B., Handkiewicz-Junak D., Wygoda Z., Jarzab B., Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer, Wiad Lek, 54, SUPPL 1, pp. 278-88, (2001)
- [10] Kukulska A., Krajewska J., Roskosz J., Handkiewicz-Junak D., Jarzab M., Paliczka E., Puch Z., Wygoda Z., Gubaa E., Jarzab B., Optimization of 131I ablation in patients with differentiated thyroid carcinoma: Comparison of early outcomes of treatment with 100 mCi versus 60 mCi, Pol J Endocrinol, 57, pp. 374-379, (2006)